009420 — Hanall Biopharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapFalling Star

Market Cap
KR₩1tn
Enterprise Value
KR₩1tn
Revenue
KR₩139bn

Annual balance sheet for Hanall Biopharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	90,706	80,570	53,934	56,497	24,706
Net Total Accounts Receivable
Net Total Receivables	17,261	16,884	32,152	22,550	20,523
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	129,365	118,815	111,789	113,577	85,353
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15,480	19,045	19,126	19,434	18,517
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	220,132	198,478	213,451	239,747	212,881
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23,069	22,120	28,535	37,652	34,720
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	38,859	34,986	45,195	53,529	44,529
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	181,273	163,492	168,256	186,218	168,351
Total Liabilities & Shareholders' Equity	220,132	198,478	213,451	239,747	212,881
Total Common Shares Outstanding